Ocrelizumab is a ground-breaking new drug for multiple sclerosis designed to target the immune system which is attacking our brains.
A good thing or a bad thing, only you can decide.
Ocrelizumab is a ground-breaking new drug for multiple sclerosis designed to target the immune system which is attacking our brains.
A good thing or a bad thing, only you can decide.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.